Clinical Trials Logo

Clinical Trial Summary

The aim of this study was to initially evaluate the optimal dose, efficacy, and safety of vitamin D3 for reducing recurrence of recurrent urinary tract infections (rUTIs).

Clinical Trial Description

Urinary tract infection (UTI) is a multiple disease that ranks second only to respiratory infections in infectious diseases and is one of the most common infectious diseases among adults. After the first urinary tract infection, the probability of recurrence within half a year and within one year was as high as 24% and 70%, respectively. Urinary tract infection itself has the characteristics of easy recurrence, which is closely related to the abuse of antibiotics, the generation of bacterial resistance, and the decline of local immune function of mucosa. In the urinary tract, the antibacterial peptide Cathelicidin is mainly located in the proximal tubules of the kidney and the epithelial cells of the renal pelvis and ureter. LL37 is the only antibacterial peptide present in the human body of the Cathelicidin family, which can be regarded as a natural antibiotic produced by the body. Antibacterial peptides have a broad-spectrum antibacterial effect and can exert antibacterial effects against both Gram-positive and Gram-negative bacteria. Vitamin D intake increases the activity of endogenous antimicrobial peptides. Preclinical cell test of Zensun Sci. & Tech. Co., Ltd. confirmed the induction of LL37 in urethral epithelial cells by vitamin D and its broad-spectrum antibacterial effect. Animal experiments also showed the therapeutic effect of LL37 on UTI. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT04859621
Study type Interventional
Source Zensun Sci. & Tech. Co., Ltd.
Contact Xiaorui Wang, Ph.D
Phone 86-21-50802627
Email [email protected]
Status Not yet recruiting
Phase Phase 2
Start date April 30, 2021
Completion date July 30, 2023

See also
  Status Clinical Trial Phase
Completed NCT02357758 - Effects of Antibiotic Prophylaxis on Recurrent UTI in Children Phase 4
Completed NCT04306731 - Effect of Nanotechnology Structured Water Magnalife for the Prevention of Recurrent Urinary Tract Infections. N/A
Completed NCT01958073 - Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women Phase 4
Recruiting NCT04807894 - Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo Phase 4
Enrolling by invitation NCT04077580 - The Effect of Methenamine Hippurate to Reduce Antibiotic Prescribing in Elderly Women With Recurrent UTI Phase 4
Recruiting NCT03143920 - Hyperbaric Oxygen Therapy for Inflammatory Conditions of the Urinary Bladder Early Phase 1
Not yet recruiting NCT03854396 - Clinical Trial on the Preventive Effect of Intravaginal Prasterone on Recurrent Urinary Tract Infections in Postmenopausal Women Phase 3
Recruiting NCT02705495 - Acupuncture for Prevention of Recurrent Urinary Tract Infections. N/A
Not yet recruiting NCT04285320 - Antibiotic Bladder Instillations vs. Oral Suppression for the Treatment of Recurrent Urinary Tract Infections Phase 4
Recruiting NCT03142295 - Controlled Human Urine Transfusion for UTI N/A
Not yet recruiting NCT04831840 - Recurrent Urinary Tract Infections and the Microbiome
Completed NCT00214045 - Rigid Versus Flexible Cystoscopy in Women N/A
Completed NCT01808755 - D Mannose in Recurrent Urinary Tract Infections Phase 3
Recruiting NCT01745328 - Treatment of Recurrent Urinary Tract Infection (RUTI) by Traditional Chinese Medicine N/A
Completed NCT03050515 - Fecal Microbiota Transplantation for the Treatment of Recurrent Urinary Tract Infections Early Phase 1
Completed NCT02444975 - The Effect of Increased Water Intake on the Frequency of the Clinical Recurrent Urinary Tract Infections in Pre-menopausal Women: S-HYDRACYST N/A
Not yet recruiting NCT03597152 - Nutritional Supplementation for Recurrent Urinary Tract Infections in Women N/A
Recruiting NCT03861260 - GAG Replacement vs URethral DIlAtatioN N/A
Available NCT04173013 - Expanded Access Program Using Uromune for Patients With Recurrent Urinary Tract Infections (rUTI)
Withdrawn NCT00789464 - Probiotics for Girls With Recurring Urinary Tract Infections Phase 2